Small Volume Parenteral Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

Report
113 Pages
October 2023
Region: Global
Acute Market Reports
ID: 5894140

The small-volume parenteral (SVP) market is expected to grow at a CAGR of 7.8% during the forecast period of 2023 to 2031. The SVP market is poised for substantial growth, driven by factors such as the rising prevalence of chronic diseases, advancements in drug development, and demographic shifts. While regulatory challenges pose a restraint, the market is adapting to meet quality assurance requirements. The segmentation data for form and dose type, along with geographic trends, provide valuable insights for stakeholders, enabling them to navigate this dynamic market and deliver essential medications to patients worldwide in an evolving healthcare landscape.

Increasing Prevalence of Chronic Diseases

One of the primary drivers propelling the SVP market is the rising prevalence of chronic diseases worldwide. Conditions such as diabetes, cardiovascular diseases, and cancer require ongoing management through medications, many of which are administered through injections. As the global burden of chronic diseases continues to grow, so does the demand for SVP products. Evidence supporting this driver can be found in epidemiological studies and disease prevalence reports. These sources consistently highlight the increasing incidence and prevalence of chronic diseases, underscoring the sustained need for injectable medications. Healthcare providers rely on SVP products to ensure accurate dosing and effective treatment for patients with chronic conditions.

Advancements in Drug Development

The second major driver of the SVP market is the continuous advancements in drug development. Pharmaceutical companies are increasingly focusing on developing novel medications that require parenteral administration due to factors like bioavailability, stability, and targeted drug delivery. These advancements result in a growing pipeline of injectable drugs, further fueling the demand for SVP products. Evidence for this driver can be observed in the pharmaceutical industry's R&D investments and drug approvals. The expansion of the injectable drug market, including biologics and biosimilars, highlights the importance of SVP products in drug delivery. As innovative therapies continue to emerge, the market for SVP products is expected to expand.

Aging Population and Healthcare Access

The third significant driver is the aging population and improved healthcare access. As the global population ages, there is an increased need for medications, including injectables, to address age-related health conditions. Additionally, improved healthcare access, particularly in emerging markets, ensures that a larger segment of the population has access to essential healthcare services, including injectable medications. Evidence supporting this driver can be found in demographic studies and healthcare infrastructure improvements. The aging population is associated with a higher incidence of age-related diseases and conditions, leading to greater demand for SVP products. Moreover, increased healthcare access in regions with previously limited resources expands the market's reach.

Regulatory Challenges and Quality Assurance

Despite the promising growth of the SVP market, a significant restraint is the complex regulatory environment and the stringent quality assurance requirements associated with parenteral products. Manufacturing and distributing SVP products require adherence to rigorous quality standards, including Good Manufacturing Practices (GMP) and compliance with regulatory agencies. Evidence for this restraint can be observed in regulatory guidelines and quality control processes implemented by pharmaceutical companies and SVP manufacturers. Ensuring product safety and efficacy while navigating regulatory hurdles can be time-consuming and resource-intensive. Regulatory challenges can lead to delays in product approvals and market entry, impacting the market's growth potential.

Market Segmentation by Form: Liquid SVP Products Dominate the Market

The SVP market is segmented by form into Liquid and Dry. In 2022, Liquid SVP products accounted for the highest revenue, primarily due to their widespread use in intravenous (IV) therapies and ease of administration. However, during the forecast period from 2023 to 2031, the Dry form is expected to exhibit the highest Compound Annual Growth Rate (CAGR). This shift can be attributed to the growing demand for lyophilized or powder-based injectable medications, which offer extended shelf life and stability.

Market Segmentation by Dose Type: Single-dose SVP Products Dominate the Market

The market is further segmented by Dose Type into Single-dose and Multiple-dose. In 2022, Single-dose SVP products generated the highest revenue, as they are commonly used for individual patient administration, reducing the risk of contamination and ensuring accurate dosing. However, during the forecast period from 2023 to 2031, the Multiple-dose segment is expected to experience the highest CAGR. This growth reflects the increasing adoption of multidose vials and prefilled syringes for chronic disease management, providing convenience and cost-effectiveness.

North America Remains the Global Leader

Geographic trends in the SVP market indicate that North America had the highest revenue percentage in 2022, driven by a well-established healthcare infrastructure and a robust pharmaceutical industry. However, during the forecast period from 2023 to 2031, the Asia-Pacific region is expected to exhibit the highest CAGR. This growth can be attributed to the increasing healthcare investments, rising access to healthcare services, and the expanding patient population in Asia-Pacific countries.

Market Competition to Intensify during the Forecast Period

In 2022, the top players in the SVP market included pharmaceutical companies such as Pfizer Inc., Novartis AG, Sanofi S.A., Baxter International Inc., BML Parenteral Drugs, Rusoma, B. Braun Melsungen AG, Fresenius Kabi Ag and Sichuan Kelun., among others. These organizations leveraged their extensive portfolios of injectable medications and manufacturing capabilities to maintain significant market shares. During the forecast period from 2023 to 2031, these key players are expected to continue their dominance by focusing on product innovation, expanding their global reach, and ensuring compliance with evolving regulatory standards. Additionally, partnerships and collaborations with contract manufacturing organizations (CMOs) are likely to play a pivotal role in meeting the growing demand for SVP products.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review.

Key data point that enables the estimation ofSmall Volume Parenteral market are as follows:

Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report
Micro and macro environment factors that are currently influencing the Small Volume Parenteral market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Form

Liquid
Dry

Dose Type

Single-dose
Multiple-dose

Packaging Type

Ampoules
Vials
Pre-filled Syringes
Cartridges
Bottles
Others

Indication Type

Pain Management
Cancer Care
Malnourishment
Gastrointestinal disorder/Diarrhea
Diabetes
Others

Region Segment (2021 - 2031; US$ Million)

North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Small Volume Parenteral market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Small Volume Parenteral market?
Which is the largest regional market for Small Volume Parenteral market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Small Volume Parenteral market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Small Volume Parenteral market worldwide?

This product will be delivered within 2 business days.

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Small Volume Parenteral Market
2.2. Global Small Volume Parenteral Market, By Form, 2022 (US$ Million)
2.3. Global Small Volume Parenteral Market, By Dose Type, 2022 (US$ Million)
2.4. Global Small Volume Parenteral Market, By Packaging Type, 2022 (US$ Million)
2.5. Global Small Volume Parenteral Market, By Indication Type, 2022 (US$ Million)
2.6. Global Small Volume Parenteral Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022

3. Small Volume Parenteral Market: Competitive Analysis

3.1. Market Positioning of Key Small Volume Parenteral Market Vendors
3.2. Strategies Adopted by Small Volume Parenteral Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Small Volume Parenteral Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Small Volume Parenteral Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Liquid
5.3.2. Dry

6. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Single-dose
6.3.2. Multiple-dose

7. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Ampoules
7.3.2. Vials
7.3.3. Pre-filled Syringes
7.3.4. Cartridges
7.3.5. Bottles
7.3.6. Others

8. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Pain Management
8.3.2. Cancer Care
8.3.3. Malnourishment
8.3.4. Gastrointestinal disorder/Diarrhea
8.3.5. Diabetes
8.3.6. Others

9. North America Small Volume Parenteral Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
9.3. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
9.4. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
9.5. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
9.6. Small Volume Parenteral Market: By Region, 2021-2031, USD (Million)
9.6.1. North America
9.6.1.1. U.S.
9.6.1.1.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
9.6.1.1.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
9.6.1.1.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
9.6.1.1.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
9.6.1.2.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
9.6.1.2.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
9.6.1.2.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
9.6.1.3.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
9.6.1.3.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
9.6.1.3.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)

10. UK and European Union Small Volume Parenteral Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
10.3. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
10.4. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
10.5. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
10.6. Small Volume Parenteral Market: By Region, 2021-2031, USD (Million)
10.6.1. UK and European Union
10.6.1.1. UK
10.6.1.1.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
10.6.1.1.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
10.6.1.1.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
10.6.1.1.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
10.6.1.2.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
10.6.1.2.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
10.6.1.2.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
10.6.1.3.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
10.6.1.3.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
10.6.1.3.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
10.6.1.4.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
10.6.1.4.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
10.6.1.4.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
10.6.1.5. France
10.6.1.5.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
10.6.1.5.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
10.6.1.5.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
10.6.1.5.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
10.6.1.6.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
10.6.1.6.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
10.6.1.6.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)

11. Asia Pacific Small Volume Parenteral Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
11.3. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
11.4. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
11.5. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
11.6. Small Volume Parenteral Market: By Region, 2021-2031, USD (Million)
11.6.1. Asia Pacific
11.6.1.1. China
11.6.1.1.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
11.6.1.1.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
11.6.1.1.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
11.6.1.1.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
11.6.1.2.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
11.6.1.2.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
11.6.1.2.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
11.6.1.3. India
11.6.1.3.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
11.6.1.3.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
11.6.1.3.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
11.6.1.3.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
11.6.1.4.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
11.6.1.4.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
11.6.1.4.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
11.6.1.5.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
11.6.1.5.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
11.6.1.5.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
11.6.1.6.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
11.6.1.6.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
11.6.1.6.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)

12. Latin America Small Volume Parenteral Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
12.3. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
12.4. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
12.5. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
12.6. Small Volume Parenteral Market: By Region, 2021-2031, USD (Million)
12.6.1. Latin America
12.6.1.1. Brazil
12.6.1.1.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
12.6.1.1.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
12.6.1.1.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
12.6.1.1.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
12.6.1.2.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
12.6.1.2.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
12.6.1.2.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
12.6.1.3.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
12.6.1.3.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
12.6.1.3.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)

13. Middle East and Africa Small Volume Parenteral Market, 2021-2031, USD (Million)

13.1. Market Overview
13.2. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
13.3. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
13.4. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
13.5. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
13.6. Small Volume Parenteral Market: By Region, 2021-2031, USD (Million)
13.6.1. Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
13.6.1.1.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
13.6.1.1.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
13.6.1.1.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
13.6.1.2.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
13.6.1.2.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
13.6.1.2.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Small Volume Parenteral Market: By Form, 2021-2031, USD (Million)
13.6.1.3.2. Small Volume Parenteral Market: By Dose Type, 2021-2031, USD (Million)
13.6.1.3.3. Small Volume Parenteral Market: By Packaging Type, 2021-2031, USD (Million)
13.6.1.3.4. Small Volume Parenteral Market: By Indication Type, 2021-2031, USD (Million)

14. Company Profile

14.1. Pfizer Inc.
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Novartis AG
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Sanofi S.A.
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Baxter International Inc.
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. BML Parenteral Drugs
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Rusoma
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. B. Braun Melsungen AG
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Fresenius Kabi Ag
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Sichuan Kelun
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Other Notable Players
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives

List of Figures

Figure 1 Global Small Volume Parenteral Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Small Volume Parenteral Market: Quality Assurance
Figure 5 Global Small Volume Parenteral Market, By Form, 2022
Figure 6 Global Small Volume Parenteral Market, By Dose Type, 2022
Figure 7 Global Small Volume Parenteral Market, By Packaging Type, 2022
Figure 8 Global Small Volume Parenteral Market, By Indication Type, 2022
Figure 9 Global Small Volume Parenteral Market, By Geography, 2022
Figure 10 Market Geographical Opportunity Matrix - Global Small Volume Parenteral Market, 2022
Figure 11 Market Positioning of Key Small Volume Parenteral Market Players, 2022
Figure 12 Global Small Volume Parenteral Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 13 Global Small Volume Parenteral Market, By Form, 2022 Vs 2031, %
Figure 14 Global Small Volume Parenteral Market, By Dose Type, 2022 Vs 2031, %
Figure 15 Global Small Volume Parenteral Market, By Packaging Type, 2022 Vs 2031, %
Figure 16 Global Small Volume Parenteral Market, By Indication Type, 2022 Vs 2031, %
Figure 17 U.S. Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 18 Canada Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 19 Rest of North America Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 20 UK Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 21 Germany Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 22 Spain Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 23 Italy Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 24 France Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 25 Rest of Europe Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 26 China Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 27 Japan Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 28 India Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 29 Australia Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 30 South Korea Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 31 Rest of Asia Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 32 Brazil Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 33 Mexico Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 34 Rest of Latin America Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 35 GCC Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 36 Africa Small Volume Parenteral Market (US$ Million), 2021 - 2031
Figure 37 Rest of Middle East and Africa Small Volume Parenteral Market (US$ Million), 2021 - 2031

List of Tables

Table 1 Global Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 2 Global Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 3 Global Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 4 Global Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 5 North America Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 6 North America Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 7 North America Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 8 North America Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 9 U.S. Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 10 U.S. Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 11 U.S. Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 12 U.S. Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 13 Canada Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 14 Canada Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 15 Canada Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 16 Canada Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 17 Rest of North America Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 18 Rest of North America Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 19 Rest of North America Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 20 Rest of North America Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 21 UK and European Union Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 22 UK and European Union Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 23 UK and European Union Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 24 UK and European Union Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 25 UK Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 26 UK Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 27 UK Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 28 UK Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 29 Germany Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 30 Germany Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 31 Germany Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 32 Germany Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 33 Spain Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 34 Spain Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 35 Spain Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 36 Spain Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 37 Italy Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 38 Italy Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 39 Italy Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 40 Italy Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 41 France Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 42 France Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 43 France Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 44 France Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 45 Rest of Europe Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 46 Rest of Europe Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 47 Rest of Europe Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 48 Rest of Europe Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 49 Asia Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 50 Asia Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 51 Asia Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 52 Asia Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 53 China Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 54 China Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 55 China Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 56 China Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 57 Japan Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 58 Japan Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 59 Japan Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 60 Japan Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 61 India Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 62 India Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 63 India Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 64 India Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 65 Australia Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 66 Australia Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 67 Australia Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 68 Australia Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 69 South Korea Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 70 South Korea Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 71 South Korea Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 72 South Korea Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 73 Latin America Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 74 Latin America Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 75 Latin America Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 76 Latin America Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 77 Brazil Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 78 Brazil Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 79 Brazil Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 80 Brazil Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 81 Mexico Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 82 Mexico Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 83 Mexico Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 84 Mexico Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 85 Rest of Latin America Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 86 Rest of Latin America Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 87 Rest of Latin America Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 88 Rest of Latin America Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 89 Middle East and Africa Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 90 Middle East and Africa Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 91 Middle East and Africa Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 92 Middle East and Africa Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 93 GCC Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 94 GCC Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 95 GCC Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 96 GCC Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 97 Africa Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 98 Africa Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 99 Africa Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 100 Africa Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)
Table 101 Rest of Middle East and Africa Small Volume Parenteral Market By Form, 2021-2031, USD (Million)
Table 102 Rest of Middle East and Africa Small Volume Parenteral Market By Dose Type, 2021-2031, USD (Million)
Table 103 Rest of Middle East and Africa Small Volume Parenteral Market By Packaging Type, 2021-2031, USD (Million)
Table 104 Rest of Middle East and Africa Small Volume Parenteral Market By Indication Type, 2021-2031, USD (Million)

Companies Mentioned

Pfizer Inc.
Novartis AG
Sanofi S.A.
Baxter International Inc.
BML Parenteral Drugs
Rusoma
B. Braun Melsungen AG
Fresenius Kabi Ag
Sichuan Kelun

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4371EUR$4,500USD£3,734GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6313EUR$6,500USD£5,393GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8741EUR$9,000USD£7,468GBP